The pharmaceutical company Roche has added more hybrids
to its fleet, which now stands at 242 and move about 15 percent of the company's sales reps on their journeys. Roche started buying hybrids – Toyota Priuses and Ford Escape hybrids (pictured) – in 2004. The reasons will be familiar to fleet managers across the world: lower operating (fuel) costs and Roche says the lowered emissions and positive driving experiences of these vehicles were also factors in replacing standard vehicles with hybrids. The company estimates that these vehicles "will result in greenhouse gas emissions reductions of 1,033.5 tons and gasoline savings of more than 80,253 gallons each year." Makes me wonder how a pill called the Roche Escape would sell?
The press release is here
[Source: Roche via EV World]